Related Experiment Video
Updated: Aug 7, 2026
06:49
Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
A network of protein interactions determines polyglutamine toxicity
Martin L Duennwald1, Smitha Jagadish, Flaviano Giorgini
1Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
Summary
Misfolded protein toxicity in neurodegenerative diseases is influenced by protein sequence and cellular environment. Yeast models show these factors can convert toxic polyglutamine proteins to benign, and vice versa.
Area of Science:
- Neurobiology
- Molecular Biology
- Protein Chemistry
Background:
- Neurodegenerative diseases are linked to misfolded protein toxicity.
- Polyglutamine (polyQ) diseases, caused by glutamine expansions, exhibit diverse pathologies despite shared protein origins.
- Intramolecular and intermolecular factors significantly modulate protein toxicity.
Purpose of the Study:
- To investigate how amino acid sequences and cellular environment influence polyglutamine protein toxicity.
- To explore the interplay between intramolecular features and intermolecular factors in polyQ diseases.
- To understand the mechanisms underlying the diverse pathobiology of polyQ expansion proteins.
Main Methods:
- Utilized a yeast model system to study polyglutamine toxicity.
- Assessed the impact of amino acid sequences in cis and trans on polyQ toxicity.
- Investigated the role of Rnq1 prion conformation and expression levels of other glutamine-rich proteins.
Main Results:
- Amino acid sequences modulating polyQ toxicity in cis were also found to modulate it in trans.
- The prion conformation of Rnq1 and expression levels of glutamine-rich proteins significantly affected polyQ toxicity.
- Polyglutamine expansion proteins could be converted from toxic to benign states and vice versa by these factors.
Conclusions:
- A complex interplay between intramolecular protein features and intermolecular cellular factors determines polyQ protein pathobiology.
- This dynamic interaction provides a paradigm for understanding the unique disease mechanisms in polyQ expansion disorders.
- Modulating these factors offers potential therapeutic strategies for neurodegenerative diseases involving misfolded proteins.
Related Concept Videos
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:25Protein Folding
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...